DERMATOLOGIC AND OPHTHALMIC DRUGS ADVISORY COMMITTEE
November 16, 2000
Tacrolimus Ointment
NDA 50-777
Briefing Information
Fujisawa Healthcare, Inc.
Disclaimer
The statements contained in this document are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.
Food & Drug Administration